MELASCEND Trademark

Trademark Overview

On Wednesday, August 3, 2011, a trademark application was filed for MELASCEND with the United States Patent and Trademark Office. The USPTO has given the MELASCEND trademark a serial number of 85388946. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, January 15, 2022. The MELASCEND trademark is filed in the Pharmaceutical Products category with the following description:

Chemical preparations for pharmaceutical or medical purposes, namely, for autism spectrum disorders and Alzheimer's disorder; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autism spectrum disorders and Alzheimer's disorder; Pharmaceutical preparations for the treatment of immune system related diseases and disorde...
melascend

General Information

Serial Number85388946
Word MarkMELASCEND
Filing DateWednesday, August 3, 2011
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, January 15, 2022
Registration Number4466840
Registration DateTuesday, January 14, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 14, 2012

Trademark Statements

Goods and ServicesChemical preparations for pharmaceutical or medical purposes, namely, for autism spectrum disorders and Alzheimer's disorder; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autism spectrum disorders and Alzheimer's disorder; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autism spectrum disorders and Alzheimer's disorder; Pharmaceutical preparations for autism spectrum disorders and Alzheimer's disorder

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 8, 2011
Primary Code005
First Use Anywhere DateMonday, March 25, 2013
First Use In Commerce DateMonday, March 25, 2013

Trademark Owner History

Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressCharlotte, NC 28270
Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressKingsport, TN 37663
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressKingsport, TN 37663

Trademark Events

Event DateEvent Description
Saturday, August 6, 2011NEW APPLICATION ENTERED
Monday, August 8, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, November 27, 2011ASSIGNED TO EXAMINER
Friday, December 2, 2011NON-FINAL ACTION WRITTEN
Friday, December 2, 2011NON-FINAL ACTION E-MAILED
Friday, December 2, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, December 18, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 18, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 19, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 9, 2012ASSIGNED TO LIE
Monday, January 9, 2012DATA MODIFICATION COMPLETED
Monday, January 9, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 12, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 25, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 14, 2012PUBLISHED FOR OPPOSITION
Tuesday, February 14, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 10, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 9, 2012SOU TEAS EXTENSION RECEIVED
Tuesday, October 9, 2012SOU EXTENSION 1 FILED
Tuesday, October 9, 2012SOU EXTENSION 1 GRANTED
Thursday, October 11, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 6, 2013TEAS STATEMENT OF USE RECEIVED
Saturday, April 6, 2013USE AMENDMENT FILED
Wednesday, May 1, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 3, 2013STATEMENT OF USE PROCESSING COMPLETE
Monday, May 20, 2013SU - NON-FINAL ACTION - WRITTEN
Monday, May 20, 2013NON-FINAL ACTION E-MAILED
Monday, May 20, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 5, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 13, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 13, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 4, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sunday, December 8, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, December 10, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 14, 2014REGISTERED-PRINCIPAL REGISTER
Monday, January 14, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, May 20, 2020TEAS SECTION 8 & 15 RECEIVED
Saturday, August 8, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, August 8, 2020POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Wednesday, December 30, 2020TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, February 19, 2021POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Friday, February 19, 2021POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Wednesday, March 24, 2021TEAS PETITION TO DIRECTOR RECEIVED
Wednesday, October 20, 2021ASSIGNED TO PETITION STAFF
Thursday, October 28, 2021PETITION INQUIRY LETTER ISSUED
Saturday, November 20, 2021TEAS RESPONSE TO PETITION INQUIRY LETTER
Friday, January 14, 2022PETITION TO DIRECTOR GRANTED
Saturday, January 15, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, January 15, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, January 14, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, July 17, 2023TEAS SECTION 8 & 9 RECEIVED
Saturday, January 13, 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Saturday, January 13, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Related Keywords

melascend preparations pharmaceutical treatment diseases disorders substances system immune disorder psychiatric